Plasma growth hormone is a strong predictor of risk at 1 year in acute heart failure

Aims We sought to compare the prognostic utility of growth hormone (GH) with NT‐proBNP) and the ADHERE score in a large cohort of acute heart failure (HF) patients, subcategorized into HF with reduced EF

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of heart failure 2016-03, Vol.18 (3), p.281-289
Hauptverfasser:	Bhandari, Sanjay S., Narayan, Hafid, Jones, Donald J.L., Suzuki, Toru, Struck, Joachim, Bergmann, Andreas, Squire, Iain B., Ng, Leong L.
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute Disease Acute heart failure ADHERE score Aged Aged, 80 and over Biomarkers - blood Cohort Studies Female Growth hormone Growth Hormone - blood Heart Failure - blood Heart Failure - mortality Humans Male Natriuretic Peptide, Brain - blood NT-proBNP Peptide Fragments - blood Prognosis Risk Assessment Stroke Volume
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Aims We sought to compare the prognostic utility of growth hormone (GH) with NT‐proBNP) and the ADHERE score in a large cohort of acute heart failure (HF) patients, subcategorized into HF with reduced EF
ISSN:	1388-9842 1879-0844
DOI:	10.1002/ejhf.459